NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

You did not say anything new here that changes the analysis. No one is “hiding behind a buffer”. There is a policy, and it allows for what was done. Some may not like that we already know that the product improves OS and in a statistically significant way, before publication and that that makes this investment easier to assess at this stage for those paying attention to this end of the market, but that is a fact.

It’s a reality that no number of posts saying otherwise will change.